Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy

Phase 1 Study of Autologous-Derived Stem Cell Transplantation in Patients With Lipodystrophy

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00715546

Acronym

AADSCTPL

Enrollment

Registered

2008-07-15

Start date

2007-10-31

Completion date

2011-11-30

Last updated

2011-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipodystrophy

Keywords

Adipose-derived stem cell, Lipodystrophy

Brief summary

The aim of this study is to determine the safety of the autologous transplantation of adipose-derived stem cells in the treatment of lipodystrophies.

Interventions

PROCEDUREautologous transplantation of liposuction material enriched with adipose-derived stem cells

Lipoinjection enriched with adipose-derived stem-cells.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* lipodystrophies with necessity of fat grafting * accept to participate of the study

Exclusion criteria

* HIV infection * Metastatic malignancy * Body mass index \< 20 kg/m² * Other severe systemic disease

Design outcomes

Primary

Measure	Time frame
Clinical evaluation of the transplanted area.	one year

Secondary

Measure	Time frame
Presence of neovascularization, adipose transplantation reabsorption, tissue viability	one year

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026